Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
Sponsor: Wayne State University
Summary
This preliminary study is designed to evaluate mechanisms by which excitatory dorsolateral prefrontal cortex (dlPFC) repetitive transcranial magnetic stimulation (rTMS) (vs. sham) and pharmacological stress (vs. placebo) alter behavior in non-treatment seeking individuals with opioid use disorder (OUD). Specific Aims are to (1) Evaluate how stress impacts domains of behavior including (1a) executive function and (1b) opioid-seeking behavior; and (2) Determine whether rTMS stimulation attenuates (2a) executive dysfunction, (2b) stress-reactivity, and (2c) opioid-seeking in individuals with OUD not receiving treatment.
Official title: Effects of Pharmacological Stress and Repetitive Transcranial Magnetic Stimulation Interventions on Executive Function in Opioid Use Disorder
Key Details
Gender
All
Age Range
21 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-10
Completion Date
2028-12
Last Updated
2025-12-30
Healthy Volunteers
No
Conditions
Interventions
Yohimbine + Hydrocortisone
Yohimbine (54mg bulk powder inside capsule) administered in combination with Hydrocortisone (20mg tablet inside capsule)
Active rTMS
10Hz rTMS over the left dlPFC
Placebo
lactose (inside capsule)
Sham rTMS
inactive stimulation over the left dlPFC
Locations (1)
Tolan Park Medical Building
Detroit, Michigan, United States